AI Science Tracker
EN

Integrative analysis of histopathological images and chromatin accessibility data for estrogen receptor-positive breast cancer.

Institute of Intelligent System and Bioinformatics, College of Automation, Harbin Engineering University, Harbin, Heilongjiang, China · 28 Dec 2020 · medicine

Discovery

Integrative analysis of histopathological images and chromatin accessibility data for estrogen receptor-positive breast cancer.

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: Primary BMC Medical Genomics Methods/Results integrate CNN-derived epithelial proportions with matched ATAC-seq and RNA-seq; 436 regions/74 target genes correlate with epithelial proportion and combined image+gene features stratify survival. Only 54 paired cases support peak discovery and causality is untested.

Technology: CNN segments epithelial/stromal tissue; correlation/peak-to-gene analysis integrates ATAC-seq/RNA-seq and patient outcome features.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
CNN segments epithelial/stromal tissue; correlation/peak-to-gene analysis integrates ATAC-seq/RNA-seq and patient outcome features.
Limitation / still unknown
Results are limited to the reported models, cohorts, datasets or experiments; broader generalization and clinical or operational benefit were not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://link.springer.com/article/10.1186/s12920-020-00828-4

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.